Peptide 'beginner cheat sheets' on TikTok: what the science says

What's this video probably claiming?

Based on the caption, hashtags, and creator handle, this video is almost certainly presenting a curated "starter list" of peptides marketed to men new to the space. The compounds likely covered include BPC-157, TB-500, CJC-1295, ipamorelin, and possibly MK-677, framed as approachable entry points for gym-goers who want recovery or body composition benefits. The framing of "compound research" is a common soft-sell tactic, implying these are substances people passively study rather than inject. The GLP hashtag suggests the creator may also be drawing loose comparisons to GLP-1 receptor agonists to ride that cultural wave. This kind of cheat sheet format is designed to feel informative and harm-neutral, but it's doing real persuasive work by normalizing a stack of largely unregulated, unproven-in-humans substances to an audience that may not know the difference between a peer-reviewed study and a bodybuilding forum post.

What does the science actually show?

The honest answer is: not much, in humans. BPC-157 has shown accelerated tendon and soft tissue healing in rodent models, including Staresinic et al. (2003, Journal of Orthopaedic Research), but no completed randomized controlled trials in humans exist as of 2024. TB-500, a synthetic fragment of thymosin beta-4, similarly has animal data suggesting angiogenesis and muscle repair, but human trials are absent from the literature. CJC-1295 with DAC does raise IGF-1 levels, as shown in Teichman et al. (2006, Journal of Clinical Endocrinology and Metabolism), where a 2 mg dose elevated IGF-1 by roughly 50 to 100 percent over baseline for days, but long-term safety data is nonexistent. Ipamorelin is a selective ghrelin mimetic with a cleaner side-effect profile than older GHRPs, but again, the clinical trial record is thin. MK-677 is not a peptide at all. It is an orally active ghrelin receptor agonist, and chronic use has been associated with insulin resistance and increased fasting glucose in clinical studies, including one by Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism).

Where does the social media noise diverge from clinical reality?

The gap is wide. Content like this consistently presents animal-model findings as near-certain human outcomes, which is not how pharmacology works. The leap from "healed a rat tendon" to "great for your gym recovery" skips about fifteen years of required clinical development. The framing of these compounds as beginner-friendly is also worth scrutinizing. Beginners, by definition, lack the knowledge to assess injection sterility, dosing accuracy, peptide purity, or contraindication risk. Compounded peptides sold through gray-market vendors have no guaranteed sterility, potency, or identity verification. A 2022 analysis published in JAMA found significant labeling inaccuracies in compounded hormone products, a finding that applies equally to this category. The creator's use of "structured tracking" language mimics clinical trial methodology to create a false sense of rigor. Self-tracking your response to an unstudied compound is not a substitute for a controlled trial. It is anecdote with a spreadsheet.

What should you actually know?

If you are a man interested in performance, recovery, or body composition, the substances with the strongest human evidence are not on this list. Progressive resistance training, adequate protein intake above 1.6 g per kg of body weight per day per Morton et al. (2018, British Journal of Sports Medicine), quality sleep, and creatine monohydrate (the most studied ergogenic aid in existence) will outperform any unproven peptide stack in both safety and documented efficacy. For people with genuine growth hormone deficiency or specific clinical indications, evidence-based options exist under physician supervision. The problem with cheat sheets like this one is not that the compounds are necessarily harmful in every case. It is that they are being recommended to people with zero clinical context, no baseline labs, no physician oversight, and no ability to source verified product. That is a real risk being dressed up as fitness optimization content.